Neurogene (NGNE) Interest Coverage Ratio (QoQ) (2013 - 2026)
Neurogene (NGNE) Interest Coverage Ratio (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Neurogene | 771.78 Mn | 771.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.98% |
| Dec 31, 2025 | -335,365.59% |
| Sep 30, 2025 | 52.80% |
| Jun 30, 2025 | 53.04% |
| Mar 31, 2025 | -566.29% |
| Dec 31, 2024 | -401.10% |
| Sep 30, 2024 | 25.64% |
| Jun 30, 2024 | -155.73% |
| Mar 31, 2024 | 99.99% |
| Dec 31, 2023 | -29.08% |
| Sep 30, 2023 | -353.09% |
| Jun 30, 2023 | 80.67% |
| Mar 31, 2023 | -1,420,857.59% |
| Dec 31, 2022 | 99.79% |
| Sep 30, 2022 | 32.89% |
| Jun 30, 2022 | 59.83% |
| Mar 31, 2022 | -91,014.78% |
| Dec 31, 2021 | 28.37% |
| Sep 30, 2021 | -46.16% |
| Jun 30, 2021 | -56.68% |